Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Allazo Health CEO at Wharton Health Care Conference Shows how Predictive Analytics and Individualized Intervention Targeting



   Allazo Health CEO at Wharton Health Care Conference Shows how Predictive
    Analytics and Individualized Intervention Targeting Promote Medication
                                  Adherence.

PR Newswire

PHILADELPHIA, Feb. 15, 2013

PHILADELPHIA, Feb. 15, 2013 /PRNewswire/ -- Allazo Health's CEO, Clifford
Jones will be presenting at the 19^th annual Wharton Health Care Conference
today. Other speakers include Bruce Broussard, President and CEO of Humana;
Gary L. Gottlieb, MD, President and CEO of Partners HealthCare; and Kent
Thiry, Co-Chairman and CEO of DaVita.

During the presentation, Jones will discuss details of Allazo Health's
AllazoEngine™ and share data on the impact it has had on improving patients'
medication adherence.

Allazo Health's AllazoEngine, is an analytics service that provides an
effective and cost-efficient solution to the complex problem of medication
non-adherence for health insurers, pharmacy benefit management companies,
integrated delivery networks, and accountable care organizations. Allazo
Health's unique proprietary technology not only predicts which patients will
be non-adherent to each of their medications, but also predicts how individual
patients will respond to various types of intervention efforts. Intervention
methods, for example calls from a pharmacist when patients start new
medications, informational mailings, or automated calls when patients are late
to refill their medication, impact medication adherence in different ways for
different patients.  By analyzing patient data with its patent pending
AllazoEngine, Allazo Health provides clients with an optimal medication
adherence intervention strategy targeted to individual patients.

AllazoEngine's analytics financially benefits clients by raising adherence
program ROI, reducing medical spending, reducing readmissions, increasing
HEDIS scores, and improving Medicare Star ratings.

Jones' experience includes building the Pharmacy Advisor medication adherence
program that won awards from URAC and the Pharmacy Benefit Management
Institute (PBMI), and has been used with more than 14 million patients.

About Allazo
Health:                                                           

Allazo Health is an analytics firm that provides medication adherence
solutions and services to health insurers, PBMs, integrated delivery networks,
and ACOs. Combining cutting-edge behavioral science research, medication
adherence expertise, and predictive analytics, Allazo Health is able to
forecast patients' adherence to each of their medications and identify the
most effective intervention strategies for individual patients. More
information about Allazo Health can be found at http://www.allazohealth.com.

Contact:
Clifford Jones, CEO
cliff@allazohealth.com

About Wharton Health Care Business Conference:

Now in its 19th year, the conference is a leading healthcare forum for
industry professionals, policy-makers, and academics. The annual two-day event
draws approximately 700 attendees from across the nation. To learn more about
the conference, visit http://www.whcbc.org.

SOURCE Allazo Health

Website: http://www.allazohealth.com
Contact: Clifford Jones, CEO, +1-269-208-3394
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement